Skip to content

Precision Medicine of Diabetes Program in China

Precision Medicine of Diabetes Program in China

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06320600
Acronym
PDC
Enrollment
120000
Registered
2024-03-20
Start date
2023-07-01
Completion date
2028-12-31
Last updated
2024-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Brief summary

The prevalence of diabetes has been increasing year by year. According to the International Diabetes Federation (IDF) statistics in 2021, the global number of people with diabetes has reached 537 million. The patient population is large and heterogeneous, and precise diagnosis and treatment of diabetes patients have been a focus of attention. The objective of this study is to clarify the current status of precision classification and diagnosis of diabetes patients through retrospective and prospective cohort studies, and to establish a model for precision classification and diagnosis of diabetes, improving the accuracy of diabetes classification and diagnosis; based on big data of precision medicine for diabetes patients and follow-up cohorts, to establish precise diagnostic, therapeutic, and predictive methods for diabetes; and through multi-omics data analysis, to explore the potential pathogenesis of diabetes, explaining the heterogeneity of patients, and guiding individualized treatment for patients.

Interventions

OTHERno intervention

It's an observational study, no intervention included

Sponsors

Second Xiangya Hospital of Central South University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed with diabetes according to WHO 1999 criteria

Exclusion criteria

* with duration more than 1 year; Diabetes has not been diagnosed by WHO standards in 1999; Absence of medical history data

Design outcomes

Primary

MeasureTime frameDescription
The currency analysis of diabetes classificationJuly 1st 2023 to December 31th 2023To assess the accuracy rate of diabetes classification diagnoses according to Classification of diabetes mellitus in China: an expert consensus statement and explore variations across centers in different regions and hospital levels.

Secondary

MeasureTime frameDescription
To establish a model for predicting diabetic retinopathyJanuary 1st 2024 to December 31th 2028To establish a model for diabetic retinopathy prediction, and calculate the sensitivity and specificity of the model were by comparing with the retinopathy outcome of patients.
To establish a model for predicting diabetic kidney diseaseJanuary 1st 2024 to December 31th 2028To establish a model for diabetic kidney disease (DKD) prediction, and calculate the sensitivity and specificity of the model were by comparing with the DKD outcome of patients.
To establish a model for predicting diabetic neuropathyJanuary 1st 2024 to December 31th 2028To establish a model for diabetic neuropathy prediction, and calculate the sensitivity and specificity of the model were by comparing with the outcome of patients.

Other

MeasureTime frameDescription
To establish a model for hypoglycemic therapyJanuary 1st 2024 to December 31th 2028To establish a model for hypoglycemic therapy selection, and compare the rate of HbA1c\<7% in patients who are in accordance with the model choice and those who aren't.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026